On September 2, 2022 Fate Therapeutics, Inc. (the "Company" or "Fate Therapeutics") (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, reported that the Company will participate in the following upcoming investor conferences (Press release, Fate Therapeutics, SEP 2, 2022, View Source [SID1234618933]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual BioPharma Conference on Thursday, September 8, 2022 in Boston, Massachusetts

Hosting 1×1 investor meetings only
Wells Fargo 2022 Healthcare Conference on Friday, September 9, 2022 at 8:35 AM ET in Boston, Massachusetts

Participating in a fireside chat and hosting 1×1 investor meetings
Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 2:15 PM ET in New York, New York

Participating in a fireside chat and hosting 1×1 investor meetings
Baird 2022 Global Health Conference on Tuesday, September 13, 2022 at 8:30 AM ET in New York, New York

Participating in a fireside chat only
H.C. Wainwright 24th Annual Global Investment Conference on Tuesday, September 13, 2022 at 10:00 AM ET in New York, New York

Participating in a fireside chat only
A live webcast, if recorded, of each presentation can be accessed under "Events & Presentations" in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website shortly after the event.